Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

• Status: Completed
• Trial end date: 2018-12-27
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the Pharmacokinetics and safety/tolerability between Fimasartan/Amlodipine/Hydrochlorothiazide and co administration of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boryung Pharmaceutical Co., Ltd
• Treatments: Amlodipine; Hydrochlorothiazide

Criteria

Inclusion Criteria:

• A healthy adults aged 19-50 years

Exclusion Criteria:

• History or presence of clinically significant medical or psychiatric condition or disease

• Hypersensitivity to ingredient of IP and other medication, food

• Participation in any other study within 3months

• History of whole blood donation within 2months and Apheresis 1month